ClinicalTrials.gov
public full text
Public Domain
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as baricitinib in participants with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Baricitinib (LY3009104) in Healthy Chinese Participants#993838
- Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis#1075367
- Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis#1138578
- Examination of Efficacy and Safety of Baricitinib in RA Patients#1125007
- An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis#868392
Record · ID 870812
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive